Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carrier proteins are a class of membrane-spanning proteins that facilitate the selective transport of specific molecules, such as ions, nutrients, and metabolites, across biological membranes[1][5][7]. Unlike channel proteins, carrier proteins bind to their substrates and undergo conformational changes to move them across the membrane. They may mediate transport by passive facilitated diffusion (down a concentration gradient) or by active transport (against a gradient), using energy derived from ATP hydrolysis (primary active transport) or secondary to existing ion gradients (secondary active transport)[1][3][7][9]. Major types of carrier proteins include uniporters, symporters, and antiporters, classified by the number and directionality of substrates they transport[3][9]. As a term, "carrier protein" refers to a broad functional category encompassing many specific protein families such as the solute carrier (SLC) family, ABC transporters, and others, each with distinct pharmacological and physiological attributes[2][7][10].\n\nNote:\n"Carrier protein" is a generic category, not a single, specific target or molecular entity. It refers to a very large, heterogeneous group of transport proteins. For structured drug discovery or target annotation, more specific names (e.g., "Solute carrier family 6 member 4 (SLC6A4), Serotonin transporter") are needed to avoid ambiguity. Thus, "carrier protein" is not a canonical target name, nor is it suitable as a direct therapeutic target entry without further specification.
Inhibition of substrate transport (blocker); Substrate analog competition; Altered transporter function (modulator, e.g., allosteric); Pump reversal (for some ion transporters)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carrier protein.